PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29265780
OWN - NLM
STAT- MEDLINE
DCOM- 20171222
LR  - 20171227
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 25
DP  - 2017 Dec 21
TI  - Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
PG  - 2502
LID - 10.1056/NEJMc1714163 [doi]
FAU - Imprialos, Konstantinos P
AU  - Imprialos KP
AD  - Aristotle University of Thessaloniki, Thessaloniki, Greece
AD  - [email protected]
FAU - Stavropoulos, Konstantinos
AU  - Stavropoulos K
AD  - Aristotle University of Thessaloniki, Thessaloniki, Greece
FAU - Doumas, Michael
AU  - Doumas M
AD  - George Washington University, Washington, DC
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Peptides)
RN  - 0 (Venoms)
RN  - 9P1872D4OL (exenatide)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Sep 28;377(13):1228-1239. PMID: 28910237
CIN - N Engl J Med. 2017 Dec 21;377(25):2502. PMID: 29262286
MH  - *Diabetes Mellitus, Type 2
MH  - Humans
MH  - Peptides
MH  - *Venoms
EDAT- 2017/12/22 06:00
MHDA- 2017/12/23 06:00
CRDT- 2017/12/22 06:00
PHST- 2017/12/22 06:00 [entrez]
PHST- 2017/12/22 06:00 [pubmed]
PHST- 2017/12/23 06:00 [medline]
AID - 10.1056/NEJMc1714163#SA1 [pii]
AID - 10.1056/NEJMc1714163 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Dec 21;377(25):2502. doi: 10.1056/NEJMc1714163.